Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis

Background. Herpes zoster (HZ) is a disease that mainly causes severe segmental neuralgia and vesicles after infection with herpes zoster virus (VZV). At the same time, more than 9 to 34 percent of patients have postherpetic neuralgia (PHN) present with chronic pain for months or even years. Moxibus...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanen Huang, Jingping Wu, Hongbin Cheng, Yanling Liu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Complexity
Online Access:http://dx.doi.org/10.1155/2021/5551196
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547638243753984
author Yuanen Huang
Jingping Wu
Hongbin Cheng
Yanling Liu
author_facet Yuanen Huang
Jingping Wu
Hongbin Cheng
Yanling Liu
author_sort Yuanen Huang
collection DOAJ
description Background. Herpes zoster (HZ) is a disease that mainly causes severe segmental neuralgia and vesicles after infection with herpes zoster virus (VZV). At the same time, more than 9 to 34 percent of patients have postherpetic neuralgia (PHN) present with chronic pain for months or even years. Moxibustion has been used to treat herpes zoster and postherpetic neuralgia for many years; however, there has been no comprehensive study to evaluate the efficacy and safety of moxibustion in the treatment of herpes zoster and postherpetic neuralgia. More studies evaluated the combined effects of acupuncture and moxibustion. Therefore, the purpose of this systematic review is to evaluate their efficacy and safety, so as to provide an evidence-based basis for the clinical application of moxibustion in the treatment of HZ and PHN. Method. The literature search was conducted in nine Chinese and English databases, and randomized controlled trials were pooled from their inceptions to June 2020. The included literature was screened, and data were extracted. RevMan 5.3 software and Stata software were used for statistical analysis. The primary outcome was the total effect. The secondary outcomes include VAS, NRS, and time of analgesia. Outcomes. From a total of 1957 identified studies, 31 were included in analysis (N = 2334 cases). 31 RCTs contained the experimental sample of 1185 cases and the control sample of 1149 cases reported efficiency of different moxibustions in the treatment of herpes zoster, statistical heterogeneity inspection without heterogeneity. So, we used the fixed-effects model, merge effect quantity OR = 3.89 (95% CI: 2.88∼5.25), Z = 8.86, and it suggested sample merger analysis was statistically significant. Also, the moxibustion, compared to other methods in the treatment of herpes zoster and herpes zoster neuralgia efficiency, increased significantly. The VAS scales, WMD = 1.69 (95% CI: 1.17∼2.22), and the time of analgesia, WMD = 2.41 (95% CI: 3.26∼1.73), indicated that moxibustion surpassed others in the relief of pain. NRS was just reported in one study. It was not statistically significant. There was no significant difference in adverse effects OR = 0.61 (95% CI: 0.33∼1.13), Z = 1.56 (P = 0.12). Conclusion. Moxibustion has obvious advantages over other therapies in the treatment of HZ and PHN. However, due to the obvious publication bias, the interpretation of the results should be cautious, and more rigorous randomized controlled clinical studies should be included to further confirm the results in the future.
format Article
id doaj-art-5b64bc4fc28a496b8be06e4edbec8411
institution Kabale University
issn 1076-2787
1099-0526
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Complexity
spelling doaj-art-5b64bc4fc28a496b8be06e4edbec84112025-02-03T06:43:57ZengWileyComplexity1076-27871099-05262021-01-01202110.1155/2021/55511965551196Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-AnalysisYuanen Huang0Jingping Wu1Hongbin Cheng2Yanling Liu3Clinical Research on Skin Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, ChinaDepartment of Medical Cosmetology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, ChinaDermatology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, ChinaSurgery of Chinese Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, ChinaBackground. Herpes zoster (HZ) is a disease that mainly causes severe segmental neuralgia and vesicles after infection with herpes zoster virus (VZV). At the same time, more than 9 to 34 percent of patients have postherpetic neuralgia (PHN) present with chronic pain for months or even years. Moxibustion has been used to treat herpes zoster and postherpetic neuralgia for many years; however, there has been no comprehensive study to evaluate the efficacy and safety of moxibustion in the treatment of herpes zoster and postherpetic neuralgia. More studies evaluated the combined effects of acupuncture and moxibustion. Therefore, the purpose of this systematic review is to evaluate their efficacy and safety, so as to provide an evidence-based basis for the clinical application of moxibustion in the treatment of HZ and PHN. Method. The literature search was conducted in nine Chinese and English databases, and randomized controlled trials were pooled from their inceptions to June 2020. The included literature was screened, and data were extracted. RevMan 5.3 software and Stata software were used for statistical analysis. The primary outcome was the total effect. The secondary outcomes include VAS, NRS, and time of analgesia. Outcomes. From a total of 1957 identified studies, 31 were included in analysis (N = 2334 cases). 31 RCTs contained the experimental sample of 1185 cases and the control sample of 1149 cases reported efficiency of different moxibustions in the treatment of herpes zoster, statistical heterogeneity inspection without heterogeneity. So, we used the fixed-effects model, merge effect quantity OR = 3.89 (95% CI: 2.88∼5.25), Z = 8.86, and it suggested sample merger analysis was statistically significant. Also, the moxibustion, compared to other methods in the treatment of herpes zoster and herpes zoster neuralgia efficiency, increased significantly. The VAS scales, WMD = 1.69 (95% CI: 1.17∼2.22), and the time of analgesia, WMD = 2.41 (95% CI: 3.26∼1.73), indicated that moxibustion surpassed others in the relief of pain. NRS was just reported in one study. It was not statistically significant. There was no significant difference in adverse effects OR = 0.61 (95% CI: 0.33∼1.13), Z = 1.56 (P = 0.12). Conclusion. Moxibustion has obvious advantages over other therapies in the treatment of HZ and PHN. However, due to the obvious publication bias, the interpretation of the results should be cautious, and more rigorous randomized controlled clinical studies should be included to further confirm the results in the future.http://dx.doi.org/10.1155/2021/5551196
spellingShingle Yuanen Huang
Jingping Wu
Hongbin Cheng
Yanling Liu
Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
Complexity
title Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
title_full Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
title_fullStr Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
title_full_unstemmed Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
title_short Moxibustion for Herpes Zoster and Postherpetic Neuralgia: A Meta-Analysis
title_sort moxibustion for herpes zoster and postherpetic neuralgia a meta analysis
url http://dx.doi.org/10.1155/2021/5551196
work_keys_str_mv AT yuanenhuang moxibustionforherpeszosterandpostherpeticneuralgiaametaanalysis
AT jingpingwu moxibustionforherpeszosterandpostherpeticneuralgiaametaanalysis
AT hongbincheng moxibustionforherpeszosterandpostherpeticneuralgiaametaanalysis
AT yanlingliu moxibustionforherpeszosterandpostherpeticneuralgiaametaanalysis